1. Galectin-3 Inhibits Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis by Activating Akt in Human Bladder Carcinoma Cells
   Natsuo Oka et al, 2005, Cancer Research CrossRef
2. Sulforaphane Enhances the Therapeutic Potential of TRAIL in Prostate Cancer Orthotopic Model through Regulation of Apoptosis, Metastasis, and Angiogenesis
   Sharmila Shankar et al, 2008, Clinical Cancer Research CrossRef
3. Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis Is Inhibited by Bcl-2 but Restored by the Small Molecule Bcl-2 Inhibitor, HA 14-1, in Human Colon Cancer Cells
   Frank A. Sinicrope et al, 2004, Clinical Cancer Research CrossRef
4. Silencing of Prion Protein Sensitizes Breast Adriamycin-Resistant Carcinoma Cells to TRAIL-Mediated Cell Death
   Franck Meslin et al, 2007, Cancer Research CrossRef
5. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Cooperates with Anticancer Drugs to Overcome Chemoresistance in Antiapoptotic Bcl-2 Family Members Expressing Jurkat Cells
   Alberto Ballestrero et al, 2004, Clinical Cancer Research CrossRef
6. Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms
   Sharmila Shankar et al, 2008, Molecular Cancer Therapeutics CrossRef